Jeevan Krishna Kuchipudi

Jeevan Krishna Kuchipudi

Active Director Director DIN 08207809
DIN 08207809 First appointment Feb 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 2 historical roles
Total affiliations 4 Since Feb 2019
Shareholding value •••• Premium profile

About Jeevan Krishna Kuchipudi

Data last updated:

Jeevan Krishna Kuchipudi is a Director at Jeevan Scientific Technology Limited (since 2020) and Managing Director at Nayas Laboratories Private Limited (since 2023). The companies operate in Pharma, Research & Development and Information Technology. The 2 current companies with reported revenue have a combined latest revenue of ₹50.75 Cr; the largest is Jeevan Scientific Technology Limited at ₹47.50 Cr (FY 2025). Earlier, Jeevan Krishna Kuchipudi was a Director at Krealife Bio Medical Research Private Limited (2022–2025) and Director at Enhops Solutions Private Limited (2019–2022).

DIN 08207809
Primary Designation Director
Industry Pharma
First Appointment 14 Feb 2019
Oldest Company Age 27 yrs
Largest company Jeevan Scientific Technology Limited · ₹47.50 Cr (FY 2025)
Combined revenue ₹50.75 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jeevan Scientific Technology Limited L72200TG1999PLC031016
Director02 Nov 20201999₹47.50 Cr (FY 2025)Active
Nayas Laboratories Private Limited U24290TG2022PTC167401
Managing Director05 Jul 20232022₹3.26 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Dec 20222022Active
Enhops Solutions Private Limited U72300TG2015PTC100314
Director14 Feb 20192015₹11.44 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Jeevan Scientific Technology Limited
Nayas Laboratories Private Limited
Krealife Bio Medical Research Private Limited
Enhops Solutions Private Limited
Premium access

Shareholding and investment profile for Jeevan Krishna Kuchipudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jeevan Krishna Kuchipudi

Jeevan Krishna Kuchipudi currently holds 2 directorships: Jeevan Scientific Technology Limited (Director, since 02 Nov 2020, revenue ₹47.50 Cr (FY 2025)); Nayas Laboratories Private Limited (Managing Director, since 05 Jul 2023, revenue ₹3.26 Cr (FY 2025)).

Jeevan Krishna Kuchipudi was first appointed on 14 Feb 2019 as Director at Enhops Solutions Private Limited. The most recent appointment on record is 05 Jul 2023 at Nayas Laboratories Private Limited.

The 2 current companies of Jeevan Krishna Kuchipudi that report revenue have a combined latest revenue of ₹50.75 Cr: Jeevan Scientific Technology Limited ₹47.50 Cr (FY 2025); Nayas Laboratories Private Limited ₹3.26 Cr (FY 2025).

Jeevan Krishna Kuchipudi held 2 earlier board appointments: Krealife Bio Medical Research Private Limited (Director, 28 Dec 2022 to 20 Aug 2025); Enhops Solutions Private Limited (Director, 14 Feb 2019 to 31 Jan 2022).

The current boards of Jeevan Krishna Kuchipudi's companies include Divakar Atluri (Jeevan Scientific Technology Limited), Gollapinwi Mallikarjuna (Jeevan Scientific Technology Limited), Krishna Kishore Kuchipudi (Jeevan Scientific Technology Limited), Krishna Sai Nadh Kodati (Jeevan Scientific Technology Limited), Nageswar Rao Yarllagadda (Jeevan Scientific Technology Limited), Ravipati Venkateswara Rao (Jeevan Scientific Technology Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available